Prevalence of comorbid conditions, selected behavioural characteristics, medications used, signs and symptoms, and self-reported health in the SaMi-Trop cohort.
| Variables | Valid N | N | Per cent |
|---|---|---|---|
| Comorbid conditions | 1.959 | ||
| High serum cholesterol | 785 | 40.1 | |
| Hypertension | 706 | 36.0 | |
| Diabetes mellitus | 198 | 10.1 | |
| Thyroid disorder | 159 | 8.1 | |
| Kidney disease | 143 | 7.3 | |
| Leishmaniosis | 22 | 1.2 | |
| Behavioural characteristics | 1.945 | ||
| Physical activity last week (minimal 30 min) | 434 | 22.3 | |
| Alcohol last month | 318 | 16.2 | |
| Current smoking | 143 | 7.3 | |
| Number of medicine in use | 1.959 | ||
| 0 | 589 | 30.1 | |
| 1–2 | 714 | 36.4 | |
| 3–4 | 538 | 27.5 | |
| ≥5 | 118 | 6.0 | |
| Medicine in use (yes) | 1.940 | ||
| Diuretics | 951 | 49.1 | |
| ACE | 553 | 28.6 | |
| ARBs | 550 | 28.4 | |
| Aspirin | 507 | 26.2 | |
| Amiodarone | 429 | 22.0 | |
| Carvedilol | 380 | 19.6 | |
| Digoxin | 140 | 7.2 | |
| β-blockers | 140 | 7.2 | |
| Vasodilators | 84 | 4.3 | |
| Warfarin | 11 | 0.6 | |
| Signs and symptoms or self-reported conditions (yes) | 1.924 | ||
| Heartbeat racing or beating abnormally | 1.222 | 63.5 | |
| Prolonged faintness or dizziness | 1.203 | 62.5 | |
| Problems on ECG | 1.180 | 61.3 | |
| Heart palpitations | 1.174 | 61.0 | |
| Short of breath during physical exercises | 1.143 | 59.4 | |
| Heartbeat racing at rest | 1.015 | 52.8 | |
| Heartbeat not regular | 902 | 46.9 | |
| Difficulty breathing when lying down | 752 | 39.1 | |
| Unable to climb two flights of stairs | 749 | 38.9 | |
| Awake during the night unable to breath | 683 | 35.5 | |
| Trouble swallowing | 599 | 31.1 | |
| Swelling or puffiness of the feet in the morning | 502 | 26.1 | |
| No bowel movement for three or more days | 478 | 24.8 | |
| Fainting or loss of consciousness | 429 | 22.0 | |
| Visible neck veins when standing up or sitting | 409 | 21.3 | |
| Pain when swallowing food | 342 | 17.8 | |
| Pacemaker | 110 | 6.2 | |
| Megaesophagus | 117 | 6.1 |
ARBs, angiotensin receptor blockers; SaMi-Trop, São Paulo-Minas Gerais Tropical Medicine Research Center.